Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Trivalent Split Virion Influenza Vaccine Fluviral™ (2013-2014 Season) in Adults Aged 18 Years and Older
Clinical trial NCT01878825 · COMPLETED
Trial details
- NCT number
- NCT01878825
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-18
- Primary completion
- 2013-08-09
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.